Vous avez cherché: revitacam (Maltais - Anglais)

x’inhu revitacam?
what is revitacam?

kif jaħdem revitacam?
how does revitacam work?

għal xiex jintuża revitacam?
what is revitacam used for?

aktar tagħrif dwar revitacam:
other information about revitacam:

sprejja revitacam ġo ħalq il- kelb
spray revitacam into dog’s mouth

x’benefiċċju wera revitacam matul l-istudji?
what benefit has revitacam shown during the studies?

revitacam huwa mediċina li fiha s-sustanza attiva meloxikam.
revitacam is a medicine that contains the active substance meloxicam.

revitacam ma għandux jintuża fi klieb tqal jew li qed ireddgħu.
revitacam should not be used in pregnant or lactating animals.

revitacam jintuża fil-klieb biex itaffilhom l-infjammazzjoni u l-uġigħ.
revitacam is used in dogs to relieve inflammation and pain.

revitacam m’għandux jingħata flimkien ma’ nsaids jew ma’ glukokortikosterojdi oħrajn.
revitacam must not be administered in conjunction with other nsaids or glucocorticosteroids.

revitacam 5 mg/ml sprej għall-mukuża tal-Ħalq għall-klieb meloxicam
revitacam 5 mg/ml oromucosal spray for dogs meloxicam

il-persuni li huma ipersensittivi għall-nsaids għandhom jevitaw il-kuntatt ma’ revitacam.
people who are hypersensitive to nsaids should avoid contact with revitacam.

abbażi tar-riżultati tal-istudji, revitacam tqies bijoekwivalenti għall-mediċina ta’ referenza.
based on the findings of the study, revitacam was considered to be bioequivalent to the reference medicine.

diversi studji ffukaw fuq kif revitacam ġie assorbit u l-effetti tiegħu fil-ġisem, meta mqabbla ma’ metacam.
various studies looked at how revitacam was absorbed and its effects in the body, in comparison with metacam.

għaldaqstant, il-benefiċċju ta’ revitacam jitqies li huwa l-istess bħal dak tal-mediċina ta’ referenza.
consequently, revitacam’s benefit is taken as being the same as that of the reference medicine.

l-istudji li saru fuq revitacam kienu testijiet biex jiddeterminaw il-bijoekwivalenz tiegħu ma’ metacam, mediċina ta’ referenza.
studies provided for revitacam were tests to determine that it is bioequivalent to the reference medicine, metacam.

is-cvmp ikkunsidra li, b’konformità mar-rekwiżiti tal-unjoni ewropea, revitacam kien jidher bħala bijoekwivalenti għal metacam.
the cvmp considered that, in accordance with european union requirements, revitacam has been shown to be bioequivalent to metacam.

għaldaqstant il-fehma tas-cvmp kienet li, l-istess bħal metacam, il- benefiċċji ta’ revitacam huma akbar mir-riskji tiegħu meta jintuża għall-indikazzjonijiet approvati u l- kumitat irrakkomanda li revitacam jingħata awtorizzazzjoni għat-tqegħid fis-suq.
therefore the cvmp’s view was that, as for metacam, revitacam’s benefits are greater than its risks when used for the approved indications and the